CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,839 enrolled
Drug / intervention
Blood pressure management policiesother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00716079
NCT00716079N/ACompleted
CompareCT.gov

An International Randomised Controlled Trial to Establish the Effects of Early Intensive Blood Pressure Lowering in Patients With Intracerebral Haemorrhage.

The George Institute·interventional·Posted Jul 16, 2008·Updated Dec 13, 2013

In Brief

A clinical study evaluating Blood pressure management policies for Intracerebral Hemorrhage and 2 related conditions. Completed, enrolled 2,839 participants across 62 sites in 19 countries.

Detailed Summary

The purpose of this academic lead study is to determine if a treatment strategy of early intensive blood pressure (BP) lowering compared to conservative BP lowering policy in patients with elevated blood pressure within 6 hours of acute intracerebral haemorrhage (ICH) improves the outcome of death and disability at 3 months after onset.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIntracerebral Hemorrhage, Stroke, Hypertension
CountriesArgentina, Australia, Austria, Belgium, Brazil, Chile, China, Finland, France, Germany, Hong Kong, India, Italy, Pakistan, Portugal, Spain, Switzerland, United Kingdom, United States
CollaboratorsNational Health and Medical Research Council, Australia

Timeline

N/ACompletedFinished
2009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 16, 2008
Enrollment StartSep 1, 2008
Primary CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 18.0 years ago

Interventions

Blood pressure management policiesother

The trial is an assessment of BP lowering management strategies, using routinely available drugs. There is some flexibility in the use of particular BP lowering agents to achieve BP targets.